Letter to the Editor: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer—FIGO 2023 classification

Abstract

We would like to comment on the publication by Jonathan S. Berek and his team, in which they present the new 2023 FIGO classification for endometrial cancer. 1 This guideline contains important information that enhances our understanding of the diverse biology of endometrial carcinoma (EC). It also defines precise stages and substages, which can facilitate therapeutic decision-making for oncolo-